EGUSKIZA BILBAO, ANDER
 Distribuzione geografica
Continente #
AS - Asia 106
EU - Europa 91
NA - Nord America 51
SA - Sud America 16
AF - Africa 11
OC - Oceania 1
Totale 276
Nazione #
US - Stati Uniti d'America 47
SG - Singapore 40
IT - Italia 36
HK - Hong Kong 13
BR - Brasile 11
NL - Olanda 11
KR - Corea 10
CN - Cina 9
RU - Federazione Russa 8
IN - India 7
MA - Marocco 6
SE - Svezia 6
TR - Turchia 6
CO - Colombia 5
FR - Francia 5
GB - Regno Unito 5
IE - Irlanda 5
DE - Germania 4
ES - Italia 4
PK - Pakistan 4
VN - Vietnam 4
BD - Bangladesh 3
JP - Giappone 3
AT - Austria 2
CR - Costa Rica 2
DZ - Algeria 2
ID - Indonesia 2
IQ - Iraq 2
MX - Messico 2
RO - Romania 2
TG - Togo 2
CH - Svizzera 1
DJ - Gibuti 1
FI - Finlandia 1
IR - Iran 1
PL - Polonia 1
TH - Thailandia 1
TW - Taiwan 1
WS - Samoa 1
Totale 276
Città #
Singapore 21
Verona 12
Dallas 9
Hong Kong 8
Manassas 7
Bogotá 5
Dublin 5
Nacka 5
Bengaluru 4
Casablanca 4
Chittaranjan Park 3
Enschede 3
Negrar 3
Newcastle upon Tyne 3
Pohang 3
Tokyo 3
Amsterdam 2
Ashburn 2
Beijing 2
Boston 2
Bridgeport 2
Champaign 2
Columbus 2
Dhaka 2
Fermo 2
Florence 2
Hamburg 2
Houston 2
Izmir 2
Jakarta 2
L'Hospitalet de Llobregat 2
Laghouat 2
Lomé 2
Marrakesh 2
Mexico City 2
Milan 2
Palma 2
Paris 2
Peschiera Borromeo 2
San José 2
Shanghai 2
São Paulo 2
Apia 1
Apucarana 1
Atoka 1
Bang Khae 1
Birigui 1
Biên Hòa 1
Boardman 1
Camden 1
Chicago 1
Clifton 1
Djibouti 1
Dong-gu 1
Ha Long 1
Ho Chi Minh City 1
Istanbul 1
Juiz de Fora 1
Lappeenranta 1
Leesburg 1
Lexington 1
London 1
Los Angeles 1
Neuchâtel 1
Niterói 1
Nowon-gu 1
Nuremberg 1
Osasco 1
Padova 1
Parma 1
Quận Sáu 1
Rio de Janeiro 1
Romola 1
Salvador 1
San Antonio 1
San Francisco 1
Santa Maria da Boa Vista 1
Seriate 1
Stockholm 1
Taichung 1
The Dalles 1
Vargem Grande 1
Warsaw 1
Xuzhou 1
Totale 192
Nome #
Nanoparticle-based strategies in cancer immunology: from design to clinical implementation 151
Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes 74
Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses 37
Enhancing Cancer Vaccine Efficacy: Backbone Modification with β-Amino Acids Alters the Stability and Immunogenicity of MUC1-Derived Glycopeptide Formulations 22
Totale 284
Categoria #
all - tutte 970
article - articoli 664
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 306
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202489 0 0 0 0 0 0 1 1 0 2 51 34
2024/2025149 24 10 4 24 9 8 16 11 14 5 8 16
2025/202646 26 20 0 0 0 0 0 0 0 0 0 0
Totale 284